A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of multiple escalating
doses of BMS-663513 when given in combination with paclitaxel and carboplatin.